CoChat

Human-based systems: Mechanistic NASH modelling just around the corner?

Open access
Boeckmans, Joost, Natale, Alessandra, Buyl, Karolien, Rogiers, Vera, De Kock, Joery, Vanhaecke, Tamara, Rodrigues, Robim M. · 2018 · Pharmacological Research
Cited by 53

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Abstract

Graphical abstract Figure. No caption available. &NA; Non‐alcoholic steatohepatitis (NASH) is a chronic liver disease characterized by excessive triglyceride accumulation in the liver accompanied by inflammation, cell stress and apoptosis. It is the tipping point to the life‐threatening stages of non‐alcoholic fatty liver disease (NAFLD). Despite the high prevalence of NASH, up to five percent of the global population, there are currently no approved drugs to treat this disease. Animal models, mostly based on specific diets and genetic modifications, are often employed in anti‐NASH drug development. However, due to interspecies differences and artificial pathogenic conditions, they do not represent the human situation accurately and are inadequate for testing the efficacy and safety of potential new drugs. Human‐based in vitro models provide a more legitimate representation of the human NASH pathophysiology and can be used to investigate the dysregulation of cellular functions associated with the disease. Also in silico methodologies and pathway‐based approaches using human datasets, may contribute to a more accurate representation of NASH, thereby facilitating the quest for new anti‐NASH drugs. In this review, we describe the molecular components of NASH and how human‐based tools can contribute to unraveling the pathogenesis of this disease and be used in anti‐NASH drug development. We also propose a roadmap for the development and application of human‐based approaches for future investigation of NASH.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.phrs.2018.06.029

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 32 references

Cited by

Metadata

Authors
Boeckmans, J., Natale, A., Buyl, K., Rogiers, V., De Kock, J., Vanhaecke, T., & Rodrigues, R. M.
Venue
Pharmacological Research
Publisher
Elsevier BV
Published
2018-08
Volume
134
Pages
257-267
ISSN
1043-6618 (ISSN-L)
OpenAlex
W2811388003
Cited by
53
References
32
FWCI
4.26
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.